Cost-effectiveness of left ventricular assist devices

References

• Reis SE, Holubkov R, Edmundowicz D etal Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.' AM. Coll Cardiol 30(3), 733–738 (1997).
   Google Scholar
• Stevenson WG, Stevenson LW, Middlekauff HR etal Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J. Am. Coll. Camlial 26(6), 1416–1423 (1995).
   Google Scholar
• Yusuf S, Garg R, Held P, Gorlin R. Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure. Am. J. Camlial 69(18), G64—G70 (1992).
   Google Scholar
• Cohn JN, Goldstein SO, Greenberg BH et a/. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl. J. Med. 339 (25), 1810–1816 (1998).
   Google Scholar
• Heart failure: evaluation and care of patients with left ventricular dysfunction. Clinical practice guideline No. 11Washington DC. US Department of Health and Human Services, AHCPR publication No. 94–0612 (1994).
   Google Scholar
• Mavroidis D, Sun BC, Pae WE Jr. Bridge to transplantation: the Penn State experience. Ann. Thorac. Surg 68(2), 684–687 (1999).
   Google Scholar
• Peterze B, Lonn U, Jansson K, Rutberg H, Casimir-Ahn H, Nylander E. Long-term follow-up of patients treated with an implantable left ventricular assist device as an extended bridge to heart transplantation. J. Hear t Lung 7iansplant. 21(5), 604–607 (2002).
   Google Scholar
• Portner PM, Jansen PG, Oyer PE, Wheeldon DR, Ramasamy N. Improved outcomes with an implantable left ventricular assist system: a multicenter study. Ann. Thorac. Sing. 71(1), 205–209 (2001).
   Google Scholar
• Williams MR, Oz MC. Indications and patient selection for mechanical ventricular assistance. Ann. Thorac. Surg 71(3), S86—S91 (2001).
   Google Scholar
• Sun BC, Catanese KA, Spanier TB etal 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann. Thorac. Surg. 68(2), 688–694 (1999).
   Google Scholar
• Frazier OH, Rose EA, Oz MC eta]. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J. Thorac. Cardiovasc. Surg. 122(6), 1186–1195 (2001).
   Google Scholar
• El-Banayosy A, Arusoglu L, Kizner L etal Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J. Thorac. Cardiovasc. Surg. 119(3), 581–587 (2000).
   Google Scholar
• McCarthy PM, Smedira NO, Vargo RL etal One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J. Thorac. Cardiovasc. Surg 115(4), 904–912 (1998).
   Google Scholar
• Holman WL, Davies JE, Rayburn BK etal Treatment of end stage heart disease with out-patient ventricular assist devices. Ann. Thorac. Surg. 73(5), 1489–1494 (2002).
   Google Scholar
• Morales DL, Catanese KA, Heiman DN etal Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. Thorac. Cardiovasc. Surg. 119(2), 251–259 (2000).
   Google Scholar
• DeRose JJ Jr, Umana JP, Argenziano M eta]. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J. Am. Coll Camila" 30(7), 1773–1777 (1994).
   Google Scholar
• Rose EA, Moskowitz AJ, Packer M etal The REMATCH trial: rationale, design and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann. Thorac. Slog 67(3), 723–730 (1999).
   Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ eta]. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end stage heart failure. N Eng' Med. 345(20), 1435–1443 (2001).
   Google Scholar
• Gelijns AC, Richards AF, Williams DL, Oz MC, Oliveira J, Moskowitz AJ. Evolving costs of long-term left ventricular assist device implantation. Ann. Thorac. Surg. 64(5), 1312–1319 (1997).
   Google Scholar
• Moskowitz AJ, Rose EA, Gelijns AC. The cost of long-term LVAD implantation. Ann. Thorac. Surg. 71(3 Suppl.), S195—S198 (2001).
   Google Scholar
• Morales DL, Argenziano M, Oz MC. Outpatient left ventricular assist device support: a safe and economical therapeutic option for heart failure. Frog. Camliovasc. Dis. 43(1), 55–66 (2000).
   Google Scholar
• Dew MA, Kormos RL, Winowich S et aL Quality of life outcomes in left ventricular assist system in-patients and outpatients. ASAIO J. 45(3), 218–225 (1999).
   Google Scholar
• Pennington DG, McBride LR, Peigh PS, Miller LW, Swartz MT. Eight years' experience with bridging to cardiac transplantation. J. Thorac. Camliovasc. Surg. 107(2), 472–481 (1994).
   Google Scholar
• Kizner L, Morshuis M, Milting H etal Device and patient management in a bridge-to-transplant setting. Ann. Thorac. Surg. 71(3), S98—S102 (2001).
   Google Scholar
• Rose EA. Left ventricular assist devices: evolution from bridge to transplant to long-term destination therapy. Heart Surg. Forum6(2), 119 (2003).
   Google Scholar